Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
J Diet Suppl ; 12(2): 153-72, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25166890

ABSTRACT

Fluorosis is a major health problem affecting normal physiological and metabolic functions in people living in endemic fluoride areas. The present work was aimed at investigating the role of basal, high carbohydrate low protein (HCLP) and high protein low carbohydrate (HPLC) diets and Mangifera indica fruit powder as a food supplement in fluoride-induced metabolic toxicity. Exposure to fluoride resulted in elevation of plasma glucose levels, ACP, ALP, SGPT, SGOT, and hepatic G-6-Pase activities, plasma and hepatic lipid profiles with decreased plasma protein, HDL-C, hepatic glycogen content and hexokinase activity in basal, HCLP and HPLC diet fed albino rats. However among the three diets tested, HPLC diet was found to be relatively, a better metabolic regulator. All the three formulated diets (basal, HCLP and HPLC) supplemented with mango fruit powder (5 and 10 g), decreased plasma glucose content, ACP, ALP, SGPT, SGOT and hepatic G-6-Pase activities and plasma as well as hepatic lipid profiles. These diets also elevated the hepatic glycogen content and hexokinase activities. These effects however, were prominent with the HPLC diet supplemented with mango fruit powder and, among the two doses of mango fruit powder, the higher dose (10 g) yielded more promising results. It is surmised that the micronutrients and phytochemicals present in the diets and the mango fruit could be responsible for attenuation of fluoride-induced metabolic toxicity.


Subject(s)
Diet , Fluorides/toxicity , Fruit/chemistry , Mangifera , Phytochemicals/therapeutic use , Acid Phosphatase/blood , Alanine Transaminase/blood , Alkaline Phosphatase/blood , Animals , Aspartate Aminotransferases/blood , Blood Glucose/analysis , Dietary Carbohydrates/administration & dosage , Dietary Proteins/administration & dosage , Dietary Supplements , Food, Preserved , Glucose-6-Phosphatase/metabolism , Lipids/analysis , Lipids/blood , Liver/chemistry , Liver/enzymology , Male , Phytochemicals/analysis , Rats , Water Pollutants, Chemical/toxicity
2.
Interdiscip Toxicol ; 7(2): 103-10, 2014 Jun.
Article in English | MEDLINE | ID: mdl-26109886

ABSTRACT

Consumption of fluoride leads to several physiological disturbances in carbohydrate, lipid and antioxidant metabolisms. Averrhoa carambola L. fruit (Star fruit) is a commonly consumed fruit in tropical countries and is an ingredient in folklore medicines. As the fruits have high polyphenolic and antioxidant contents, the present study was undertaken to investigate the potential of star fruit as a dietary supplement in attenuating the fluoride induced hyperglycemia, hypercholesterolemia and oxidative stress in laboratory rats. A four-week exposure to fluoride caused sustained hyperglycemia, hyperlipidemia and oxidative stress and, when the diet was supplemented with star fruit powder, carbohydrate, lipid and antioxidant profiles were restored significantly. It is surmised that the antihyperglycemic, antihypercholesterolemic and antioxidant activities of star fruit in fluoride exposed rats could be due to the presence of polyphenols, flavonoids, saponins, phytosterols, ascorbic acid and fibers in the fruit, which are all well known regulators of carbohydrate, lipid and antioxidant metabolisms. These findings suggest that star fruit can be used as a dietary supplement in fluoride endemic regions to contain fluoride induced hyperglycemia, hyperlipidemia and oxidative stress.

3.
J Pharm Bioallied Sci ; 4(3): 250-4, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22923969

ABSTRACT

Purpose of the study was to examine the antihyperglycemic and hepato-renal protective effects of Emblica officinalis (Eo) fruit as a food supplement in fluoride induced toxicity. Eo fruit powder was incorporated into the diet (2.5, 5 and 10 gm %) of fluoride exposed animals for a duration of 30 days. Fluoride exposure caused significant elevation in plasma glucose, serum glutamate oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), acid phosphatase (ACP), alkaline phosphatase (ALP) activities, hepatic glucose-6-phosphatase (G-6-Pase) and decreased hepatic glycogen content, hexokinase activity and antioxidant profiles (hepatic and renal). An inclusion of Eo fruit powder significantly reduced plasma glucose levels, SGOT, SGPT, ACP and ALP activities, hepatic G-6-Pase activity and increased hepatic glycogen content and hexokinase activity. Hepatic and renal antioxidant status of fluoride exposed animals improved upon feeding Eo fruit powder. We, therefore, conclude that E. officinalis fruit could be useful in regulating hyperglycemia and enhances antioxidant status of fluoride exposed animals.

4.
Environ Health Prev Med ; 17(6): 484-93, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22438201

ABSTRACT

OBJECTIVES: Fluoride is a serious health hazard across several nations, and chronic intake of fluoride deranges the carbohydrate, lipid and antioxidant metabolism in general. As there are limited remedial measures to prevent fluorosis, we investigated the role of tamarind leaf as a food supplement in restoration of carbohydrate, lipid and antioxidant metabolism in fluoride-exposed albino rats. METHODS: Albino rats were exposed to fluoride (100 ppm sodium fluoride) through drinking water and fed diet supplemented with tamarind leaf powder (2.5, 5 and 10 g %) for 4 weeks. Carbohydrate, lipid and antioxidant profiles were investigated in both controls and fluoride-exposed animals. RESULTS: While 4-week exposure to fluoride elevated plasma glucose and lipid profiles, simulating diabetic and hyperlipidaemic conditions, the antioxidant defence mechanisms of fluoride-exposed rats were compromised, with elevation and decline in lipid peroxidation and high-density lipoprotein (HDL)-cholesterol, respectively. When the diet was supplemented with tender tamarind leaves (used in southern India as a replacement for tamarind or other sour food ingredients), significant improvements in carbohydrate and lipid profiles occurred as evidenced by decreased plasma glucose and lipid levels, lipid peroxidation, increased hepatic glycogen content, hexokinase activity and cholesterol excretion, with simultaneous improvement in antioxidant profiles of both hepatic and renal tissues. CONCLUSIONS: These findings are significant in view of the need for cost-effective approaches to tackle fluorosis as an environmental hazard and use of food supplements as ameliorative measures.


Subject(s)
Plant Extracts/chemistry , Sodium Fluoride/toxicity , Tamarindus/chemistry , Animals , Antioxidants/analysis , Body Weight/drug effects , Carbohydrates/analysis , Carbohydrates/blood , Dose-Response Relationship, Drug , Enzymes/blood , Feeding Behavior/drug effects , India , Lipids/analysis , Liver/drug effects , Liver/enzymology , Male , Organ Size/drug effects , Plant Leaves/chemistry , Rats , Sodium Fluoride/blood , Sodium Fluoride/chemistry , Sodium Fluoride/urine
5.
Oxid Med Cell Longev ; 2011: 160408, 2011.
Article in English | MEDLINE | ID: mdl-21941605

ABSTRACT

The roots of Glycyrrhiza glabra, Withania somnifera, Asparagus racemosus, and Chlorophytum borivilianum and seeds of Sesamum indicum are ayurvedic medicinal plants used in India to treat several ailments. Our previous studies indicated that these plants possess hypolipidemic and antioxidant potential. The present study was aimed at investigating the composite effects of these plants on hypercholesterolemic rats. Three different combinations (5 gm%, given for four weeks) used in this study effectively reduced plasma and hepatic lipid profiles and increased fecal excretion of cholesterol, neutral sterol, and bile acid along with increasing the hepatic HMG-CoA reductase activity and bile acid content in hypercholesterolemic rats. Further, all three combinations also improved the hepatic antioxidant status (catalase, SOD, and ascorbic acid levels) and plasma total antioxidant capacity with reduced hepatic lipid peroxidation. Overall, combination I had the maximum effect on hypercholesterolemic rats followed by combinations II and III due to varying concentrations of the different classes of phytocomponents.


Subject(s)
Hyperlipidemias/drug therapy , Lipid Peroxidation/drug effects , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Animals , Ascorbic Acid/metabolism , Asparagus Plant/chemistry , Bile Acids and Salts/metabolism , Catalase/metabolism , Chlorophyta/chemistry , Feces/chemistry , Glycyrrhiza/chemistry , Hydroxymethylglutaryl CoA Reductases/metabolism , Hyperlipidemias/enzymology , Hyperlipidemias/metabolism , Lipids/blood , Liver/drug effects , Liver/enzymology , Liver/metabolism , Male , Plant Extracts/chemistry , Rats , Sesamum/chemistry , Superoxide Dismutase/metabolism , Withania/chemistry
6.
Toxicol Ind Health ; 27(9): 793-801, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21450928

ABSTRACT

Fluoride toxicity occurs due to high concentrations of fluoride in water sources or anthropogenic causes. The aim of the present study was to investigate the effects of an Ayurvedic drug--Pankajakasthuri (PK)--in relation to fluoride-induced toxicity in mammalian lungs. The results indicated that sodium fluoride increased lipid peroxidation and decreased enzymatic and non-enzymatic antioxidants in a concentration-dependent manner in lungs. The antioxidant potential of the lungs was suppressed maximally at 10 ppm fluoride concentration and PK at all three dose levels (i.e., 100, 200 and 300 µl) decreased fluoride induced lipid peroxidation (p < 0.05) and increased the levels of total ascorbic acid, superoxide dismutase, catalase, reduced glutathione, glutathione peroxidase and FRAP values significantly (p < 0.05) in a dose-dependent manner. When PK was examined for its effects on angiotensin-converting enzyme (ACE) activity, in fluoride-induced toxicity, the ACE activity was found to increase (p < 0.0001) in lung homogenates with all three doses. This study indicates that PK, an Ayurvedic drug, improves mammalian lung function by increasing antioxidant potential and ACE activity under the conditions of fluoride toxicity.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/toxicity , Antioxidants/pharmacology , Enzyme Activation/drug effects , Lipid Peroxidation/drug effects , Lung/drug effects , Plant Extracts/pharmacology , Sodium Fluoride/antagonists & inhibitors , Angiotensin-Converting Enzyme Inhibitors/chemistry , Animals , Antioxidants/metabolism , Ascorbic Acid/metabolism , Fluoride Poisoning/drug therapy , Fluoride Poisoning/enzymology , Fluoride Poisoning/metabolism , Glutathione/metabolism , Goats , Lung/enzymology , Lung/metabolism , Male , Medicine, Ayurvedic , Oxidation-Reduction/drug effects , Oxidoreductases/metabolism , Peptidyl-Dipeptidase A/chemistry , Peptidyl-Dipeptidase A/metabolism , Phytotherapy , Plant Preparations/chemistry , Sodium Fluoride/toxicity
7.
J Ethnopharmacol ; 127(1): 98-102, 2010 Jan 08.
Article in English | MEDLINE | ID: mdl-19799987

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Leucas cephalotes (Roth.) Spreng. (Laminaceae) is an ayurvedic traditional medicinal plant used in India, Nepal and Pakistan to treat several ailments including diabetes. AIM OF THE STUDY: The aim of the present study is to investigate the antidiabetic, antihyperlipaemic and antioxidant activities of Leucas cephalotes for its purported use in diabetes. MATERIALS AND METHODS: The ethanol extract of leaves of Leucas cephalotes was administered (150, 300 and 450 mg kg(-1)bw) to diabetes induced (IDDM and NIDDM) rats and carbohydrate, lipid, antioxidant, urea and creatinine profiles were assessed. RESULTS: All the three doses of extract decreased plasma glucose and lipid profiles and, improved the antioxidant status of both types of diabetic rats. The extract administration improved hepatic glycogen content and hexokinase activity, decreased glucose-6-phosphatase activity, blood urea, creatinine contents and decreased lipid peroxidation in diabetic rats. Of the three doses used, 450 mg kg(-1)bw dose was found to be more potent in its effects comparable to those of glibenclamide and metformin. CONCLUSION: Leucas cephalotes regulates both carbohydrate and lipid metabolism and, improves body antioxidant defense systems in both types of diabetes.


Subject(s)
Antioxidants/metabolism , Carbohydrate Metabolism/drug effects , Diabetes Mellitus, Type 1/drug therapy , Diabetes Mellitus, Type 2/drug therapy , Lamiaceae/chemistry , Lipid Metabolism/drug effects , Plant Extracts/therapeutic use , Animals , Blood Glucose/analysis , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/metabolism , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/metabolism , Dose-Response Relationship, Drug , Kidney Function Tests , Lipids/analysis , Lipids/blood , Liver/drug effects , Liver/enzymology , Liver/metabolism , Liver Glycogen/analysis , Male , Medicine, Ayurvedic , Phytotherapy , Plant Leaves/chemistry , Plants, Medicinal , Random Allocation , Rats
8.
Evid Based Complement Alternat Med ; 6(2): 219-26, 2009 Jun.
Article in English | MEDLINE | ID: mdl-18955232

ABSTRACT

Hyperlipidemia/hypercholesteremia are major risk factors for atherosclerosis and cardiovascular diseases. Root of Asparagus racemosus (AR) is widely used in Ayurvedic system of medicine in India and is known for its steroidal saponin content. This study was designed to investigate the hypocholesteremic and antioxidant potential of AR root in both normo- and hypercholesteremic animals. Normal and hypercholesteremic male albino rats were administered with root powder of AR (5 and 10 g% dose levels) along with normal and hypercholesteremic diets, respectively, for a duration of 4 weeks. Plasma and hepatic lipid profiles, fecal sterol, bile acid excretion and hepatic antioxidant activity were assessed. Inclusion of AR root powder in diet, resulted in a dose-dependant reduction in plasma and hepatic lipid profiles, increased fecal excretion of cholesterol, neutral sterol and bile acid along with increases in hepatic HMG-CoA reductase activity and bile acid content in hypercholesteremic rats. Further, AR root also improved the hepatic antioxidant status (catalase, SOD and ascorbic acid levels). No significant changes in lipid and antioxidant profiles occurred in the normocholesteremic rats administered with AR root powder. AR root appeared to be useful as a dietary supplement that offers a protection against hyperlipidemia/hypercholesteremia in hypercholesteremic animals. The results of the present study indicate that the potent therapeutic phyto-components present in AR root i.e. phytosterols, saponins, polyphenols, flavonoids and ascorbic acid, could be responsible for increased bile acid production, elimination of excess cholesterol and elevation of hepatic antioxidant status in hypercholesteremic conditions.

9.
Fitoterapia ; 79(5): 328-31, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18534772

ABSTRACT

Oral administration of the ethanolic extract of the Butea monosperma seeds (300 mg/kg b.w.) exhibited significant antidiabetic, hypolipaemic and antiperoxidative effects in non-insulin dependent diabetes mellitus rats.


Subject(s)
Butea/chemistry , Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/chemistry , Hypolipidemic Agents/chemistry , Plant Extracts/chemistry , Plant Extracts/pharmacology , Animals , Blood Glucose/drug effects , Dose-Response Relationship, Drug , Glucose Tolerance Test , Male , Plant Extracts/administration & dosage , Rats , Seeds/chemistry , Triglycerides/blood
10.
Phytother Res ; 22(5): 620-6, 2008 May.
Article in English | MEDLINE | ID: mdl-18444247

ABSTRACT

Hyperglycemia, abnormal lipid and antioxidant profiles are the most usual complications in diabetes mellitus. In the present study, the antihyperglycemic, antihyperlipemic and antioxidant potency of an ethanol extract of Costus speciosus root was investigated in alloxan-induced diabetic male (Charles Foster) rats. Four groups of alloxan diabetic rats (n = 6) were administered orally with different doses of Costus speciosus root extract (150, 300 and 450 mg/kg BW) and a standard drug, glibenclamide (600 microg/kg BW), for 4 weeks. Two groups of rats (n = 6) served as normal and diabetic controls. While the diabetic controls showed significant abnormal carbohydrate, lipid and antioxidant profiles, administration of 150 mg/kg BW dose neither improved glucose nor lipid metabolism and antioxidant levels. Administration of 300 and 450 mg/kg BW doses, however, resulted in a reversal of diabetes and its complications. Both doses significantly brought down blood glucose concentration (26.76%, 34.68%), increased glycogenesis and decreased glyconeogenesis bringing the glucose metabolism toward normalcy. These doses also reversed the hyperlipidemia by reducing plasma total lipid (12.87%, 178.24%), cholesterol (21.92%, 30.77%) and triglyceride (25.32%, 33.99%) and improved hepatic antioxidant enzyme activities. The high dose (450 mg/kg BW) was found to have more potential antioxidant activities compared with glibenclamide. It is concluded that Costus speciosus root extract possesses anti-hyperglycemic, antihyperlipemic and antioxidative effects, which may prove to be of clinical importance in the management of diabetes and its complications.


Subject(s)
Costus/chemistry , Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/pharmacology , Hypolipidemic Agents/pharmacology , Alloxan , Animals , Blood Glucose/metabolism , Body Weight/drug effects , Creatinine/metabolism , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/chemically induced , Eating/drug effects , Glucose-6-Phosphatase/metabolism , Glycogen/metabolism , Hexokinase/metabolism , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/isolation & purification , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/isolation & purification , Lipid Metabolism/drug effects , Lipids/blood , Liver/drug effects , Liver/metabolism , Male , Phytotherapy , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Rats , Triglycerides/blood
11.
Food Chem Toxicol ; 46(6): 1889-95, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18353516

ABSTRACT

Purpose of this study was to examine the dose dependant effects of sesame seed powder as a dietary supplement on hypercholesteraemic and oxidative stress conditions in male albino rats. Sesame seed (Sesamum indicum) powder was administered at 5% and 10% dose levels along with either normal or hypercholesteraemic diet for duration of four weeks. Administration of sesame seed powder to hypercholesteraemic rats resulted in a significant decline in plasma, hepatic total lipid and cholesterol levels and, plasma LDL-cholesterol levels with an increase in plasma HDL-cholesterol levels. Further, these animals also showed increased fecal excretion of cholesterol, neutral sterol and bile acid along with increases in hepatic HMG-CoA reductase activity and bile acid content. Additionally sesame seed feeding improved the hepatic antioxidant status (catalase and SOD enzyme activities) with a reduction in lipid peroxidation. No significant changes in lipid and antioxidant profiles occurred in the normocholesteraemic rats administered with sesame seed powder. These beneficial effects of sesame seed on hypercholesteraemic rats appeared to be due to its fiber, sterol, polyphenol and flavonoid content, enhancing the fecal cholesterol excretion and bile acid production and as well as increasing the antioxidant enzyme activities.


Subject(s)
Anticholesteremic Agents/pharmacology , Antioxidants/pharmacology , Diet , Sesamum/chemistry , Animals , Ascorbic Acid/analysis , Bile Acids and Salts/analysis , Bile Acids and Salts/metabolism , Body Weight/drug effects , Cholesterol/analysis , Eating , Feces/chemistry , Hydroxymethylglutaryl CoA Reductases/metabolism , Indicators and Reagents , Lipid Metabolism/drug effects , Lipid Peroxidation/drug effects , Lipids/blood , Liver/drug effects , Liver/metabolism , Male , Organ Size/drug effects , Phenylhydrazines , Phytosterols/chemistry , Rats , Seeds/chemistry , Sterols/analysis
12.
Clin Exp Pharmacol Physiol ; 34(3): 244-9, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17250646

ABSTRACT

1. The present study examined the efficacy of Chlorophytum borivilianum root (powder) in modulating the hyperlipaemic/hypercholesteraemic conditions in male albino rats. 2. Administration of C. borivilianum (0.75 and 1.5 g root powder/rat per day for 4 weeks) to hypercholesteraemic rats significantly increased high-density lipoprotein-cholesterol levels and decreased plasma and hepatic lipid profiles. 3. In addition, there were significant increases in faecal cholesterol, neutral sterol and bile acid excretion with elevated hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and bile acid production. 4. Furthermore, the hypercholesteraemic rats treated with both doses of C. borivilianum also exhibited increases in superoxide dismutase and ascorbic acid levels. 5. Normocholesteraemic animals treated with both doses of C. borivilianum root powder did not show any significant variation in either lipid or anti-oxidant profiles, except for an increase in the hepatic ascorbic acid concentration compared with their untreated counterparts. 6. The hypolipaemic/hypocholesteraemic effect of C. borivilianum root powder appears to be mediated by an increase in cholesterol turnover via increased faecal cholesterol excretion and, second, through an endogenous cholesterol conversion into bile acid. 7. Administration of C. borivilianum root powder also increased the activities of anti-oxidant enzymes and vitamin C levels, which may have enhanced the anti-oxidant capacity of the liver.


Subject(s)
Hyperlipidemias/drug therapy , Liliaceae/chemistry , Lipid Metabolism/drug effects , Animals , Antioxidants/metabolism , Ascorbic Acid/metabolism , Bile Acids and Salts/analysis , Bile Acids and Salts/metabolism , Catalase/metabolism , Cholesterol/analysis , Cholesterol/blood , Diet , Feces/chemistry , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Hypercholesterolemia/blood , Hypercholesterolemia/drug therapy , Hyperlipidemias/blood , Lipids/blood , Liver/chemistry , Liver/drug effects , Liver/metabolism , Male , Plant Extracts/pharmacology , Plant Roots/chemistry , Rats , Sterols/analysis , Sterols/metabolism , Superoxide Dismutase/metabolism , Triglycerides/blood
13.
Phytomedicine ; 14(2-3): 136-42, 2007 Feb.
Article in English | MEDLINE | ID: mdl-16713218

ABSTRACT

Hypocholesteremic and antioxidant effects of Withania somnifera (WS) Dunal (Solanaceae) were investigated in hypercholesteremic male albino rats. When the root powder of WS was added to the diet at 0.75 and 1.5 gm/rat/day, hypercholesteremic animals registered significant decreases in total lipids (-40.54%; -50.69%), cholesterol (-41.58%; -53.01%) and triglycerides (-31.25%; - 44.85%) in plasma. On the other hand, significant increases in plasma HDL-cholesterol levels (+15.10%; +17.71%), HMG-CoA reductase activity (+19.51%; +26.02%) and bile acid content (+24.64%; +30.52%) of liver were noted in these animals. A similar trend was also noted in bile acid (+22.43%;+28.52%), cholesterol (+14.21%; +17.68%) and neutral sterol (+12.40%; +18.85%) excretion in the hypercholesteremic animals with WS administration. Further, a significant decrease in lipid-peroxidation (-35.29%; -36.52%) occurred in WS administered hypercholesteremic animals when compared to their normal counterparts. However, it appeared that WS root powder is also effective in normal subjects for decreasing lipid profiles.


Subject(s)
Anticholesteremic Agents/pharmacology , Antioxidants/pharmacology , Hypercholesterolemia/prevention & control , Phytotherapy , Plant Extracts/pharmacology , Withania , Animals , Anticholesteremic Agents/administration & dosage , Anticholesteremic Agents/therapeutic use , Antioxidants/administration & dosage , Antioxidants/therapeutic use , Cholesterol/blood , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Dose-Response Relationship, Drug , Hypercholesterolemia/blood , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/enzymology , Male , Plant Extracts/administration & dosage , Plant Extracts/therapeutic use , Rats , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...